2.85 USD
-0.05 (-1.72%)
2.85 USD
0 (0%)
Taking everything into account, GDRX scores 6 out of 10 in our fundamental rating. GDRX was compared to 35 industry peers in the Health Care Technology industry. GDRX has only an average score on both its financial health and profitability. GDRX scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make GDRX a good candidate for value investing.
1. Profitability
1.1 Basic Checks
GDRX had positive earnings in the past year.
GDRX had a positive operating cash flow in the past year.
GDRX had negative earnings in 4 of the past 5 years.
In the past 5 years GDRX always reported a positive cash flow from operatings.
1.2 Ratios
GDRX has a Return On Assets of 2.40%. This is amongst the best in the industry. GDRX outperforms 85.71% of its industry peers.
GDRX has a Return On Equity of 5.29%. This is amongst the best in the industry. GDRX outperforms 91.43% of its industry peers.
The Return On Invested Capital of GDRX (5.73%) is better than 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROIC | 5.73% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 3.97%, GDRX belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
In the last couple of years the Profit Margin of GDRX has declined.
Looking at the Operating Margin, with a value of 10.37%, GDRX belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
In the last couple of years the Operating Margin of GDRX has declined.
The Gross Margin of GDRX (93.46%) is better than 100.00% of its industry peers.
GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
GDRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GDRX has less shares outstanding than it did 1 year ago.
GDRX has about the same amout of shares outstanding than it did 5 years ago.
GDRX has a better debt/assets ratio than last year.
2.2 Solvency
GDRX has an Altman-Z score of 0.48. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.48, GDRX is in line with its industry, outperforming 51.43% of the companies in the same industry.
The Debt to FCF ratio of GDRX is 4.66, which is a neutral value as it means it would take GDRX, 4.66 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of GDRX (4.66) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.81 indicates that GDRX is somewhat dependend on debt financing.
The Debt to Equity ratio of GDRX (0.81) is worse than 82.86% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Altman-Z | 0.48 |
ROIC/WACC0.54
WACC10.52%
2.3 Liquidity
GDRX has a Current Ratio of 3.11. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
GDRX has a better Current ratio (3.11) than 62.86% of its industry peers.
A Quick Ratio of 3.11 indicates that GDRX has no problem at all paying its short term obligations.
GDRX has a better Quick ratio (3.11) than 65.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 9.37% over the past year.
Measured over the past years, GDRX shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.47% on average per year.
GDRX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.30%.
The Revenue has been growing by 15.34% on average over the past years. This is quite good.
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
3.2 Future
Based on estimates for the next years, GDRX will show a very strong growth in Earnings Per Share. The EPS will grow by 25.32% on average per year.
Based on estimates for the next years, GDRX will show a small growth in Revenue. The Revenue will grow by 5.00% on average per year.
EPS Next Y11.45%
EPS Next 2Y16.13%
EPS Next 3Y16.77%
EPS Next 5Y25.32%
Revenue Next Year0.19%
Revenue Next 2Y1.53%
Revenue Next 3Y3.35%
Revenue Next 5Y5%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 8.14, the valuation of GDRX can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.92, GDRX is valued rather cheaply.
GDRX is valuated cheaply with a Price/Forward Earnings ratio of 6.40.
Based on the Price/Forward Earnings ratio, GDRX is valued cheaply inside the industry as 97.14% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.57. GDRX is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.14 | ||
| Fwd PE | 6.4 |
4.2 Price Multiples
GDRX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GDRX is cheaper than 94.29% of the companies in the same industry.
GDRX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GDRX is cheaper than 94.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.22 | ||
| EV/EBITDA | 7.31 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of GDRX may justify a higher PE ratio.
GDRX's earnings are expected to grow with 16.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y16.13%
EPS Next 3Y16.77%
5. Dividend
5.1 Amount
No dividends for GDRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.85
-0.05 (-1.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners50.75%
Inst Owner Change0%
Ins Owners11.19%
Ins Owner Change3.07%
Market Cap967.38M
Revenue(TTM)800.65M
Net Income(TTM)31.75M
Analysts76.19
Price Target4.98 (74.74%)
Short Float %8.84%
Short Ratio3.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.02%
Min EPS beat(2)-13.38%
Max EPS beat(2)-10.65%
EPS beat(4)0
Avg EPS beat(4)-9.95%
Min EPS beat(4)-13.38%
Max EPS beat(4)-7.12%
EPS beat(8)2
Avg EPS beat(8)-4.79%
EPS beat(12)6
Avg EPS beat(12)4.06%
EPS beat(16)9
Avg EPS beat(16)11.21%
Revenue beat(2)0
Avg Revenue beat(2)-2.26%
Min Revenue beat(2)-3.3%
Max Revenue beat(2)-1.22%
Revenue beat(4)0
Avg Revenue beat(4)-2.17%
Min Revenue beat(4)-3.3%
Max Revenue beat(4)-1.22%
Revenue beat(8)0
Avg Revenue beat(8)-1.92%
Revenue beat(12)1
Avg Revenue beat(12)-1.83%
Revenue beat(16)2
Avg Revenue beat(16)-1.59%
PT rev (1m)-4.58%
PT rev (3m)-8.19%
EPS NQ rev (1m)0.74%
EPS NQ rev (3m)-4.06%
EPS NY rev (1m)0.19%
EPS NY rev (3m)-3.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.38%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.14 | ||
| Fwd PE | 6.4 | ||
| P/S | 1.21 | ||
| P/FCF | 9.22 | ||
| P/OCF | 5.38 | ||
| P/B | 1.61 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.31 |
EPS(TTM)0.35
EY12.28%
EPS(NY)0.45
Fwd EY15.62%
FCF(TTM)0.31
FCFY10.85%
OCF(TTM)0.53
OCFY18.58%
SpS2.36
BVpS1.77
TBVpS-0.08
PEG (NY)0.71
PEG (5Y)N/A
Graham Number3.73
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.4% | ||
| ROE | 5.29% | ||
| ROCE | 7.26% | ||
| ROIC | 5.73% | ||
| ROICexc | 7.53% | ||
| ROICexgc | 26.92% | ||
| OM | 10.37% | ||
| PM (TTM) | 3.97% | ||
| GM | 93.46% | ||
| FCFM | 13.11% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y37.95%
ROICexgc growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score6
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.81 | ||
| Debt/FCF | 4.66 | ||
| Debt/EBITDA | 2.95 | ||
| Cap/Depr | 92.2% | ||
| Cap/Sales | 9.35% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 109.5% | ||
| Profit Quality | 330.43% | ||
| Current Ratio | 3.11 | ||
| Quick Ratio | 3.11 | ||
| Altman-Z | 0.48 |
F-Score6
WACC10.52%
ROIC/WACC0.54
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.37%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%0%
EPS Next Y11.45%
EPS Next 2Y16.13%
EPS Next 3Y16.77%
EPS Next 5Y25.32%
Revenue 1Y (TTM)1.3%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.4%
Revenue Next Year0.19%
Revenue Next 2Y1.53%
Revenue Next 3Y3.35%
Revenue Next 5Y5%
EBIT growth 1Y179.68%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year34.43%
EBIT Next 3Y15.99%
EBIT Next 5Y13.87%
FCF growth 1Y9.18%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y16.5%
OCF growth 3Y0.94%
OCF growth 5Y17.16%
GOODRX HOLDINGS INC-CLASS A / GDRX FAQ
Can you provide the ChartMill fundamental rating for GOODRX HOLDINGS INC-CLASS A?
ChartMill assigns a fundamental rating of 6 / 10 to GDRX.
What is the valuation status for GDRX stock?
ChartMill assigns a valuation rating of 9 / 10 to GOODRX HOLDINGS INC-CLASS A (GDRX). This can be considered as Undervalued.
What is the profitability of GDRX stock?
GOODRX HOLDINGS INC-CLASS A (GDRX) has a profitability rating of 6 / 10.
What is the earnings growth outlook for GOODRX HOLDINGS INC-CLASS A?
The Earnings per Share (EPS) of GOODRX HOLDINGS INC-CLASS A (GDRX) is expected to grow by 11.45% in the next year.